Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 36

2.

Meta-analysis: effects of adding salmeterol to inhaled corticosteroids on serious asthma-related events.

Bateman E, Nelson H, Bousquet J, Kral K, Sutton L, Ortega H, Yancey S.

Ann Intern Med. 2008 Jul 1;149(1):33-42. Epub 2008 Jun 3.

PMID:
18523132
3.

Inhaled salmeterol and fluticasone: a study comparing monotherapy and combination therapy in asthma.

Pearlman DS, Stricker W, Weinstein S, Gross G, Chervinsky P, Woodring A, Prillaman B, Shah T.

Ann Allergy Asthma Immunol. 1999 Mar;82(3):257-65.

PMID:
10094216
4.

Effects of salmeterol in patients with persistent asthma receiving inhaled corticosteroid plus theophylline.

Inoue H, Komori M, Matsumoto T, Fukuyama S, Matsumura M, Nakano T, Tsuda M, Matsumoto K, Kanaya A, Moriwaki A, Aizawa H, Yoshida M, Nakanishi Y.

Respiration. 2007;74(6):611-6. Epub 2006 Sep 5.

PMID:
16960440
5.
6.

Salmeterol and fluticasone propionate combined in a new powder inhalation device for the treatment of asthma: a randomized, double-blind, placebo-controlled trial.

Kavuru M, Melamed J, Gross G, Laforce C, House K, Prillaman B, Baitinger L, Woodring A, Shah T.

J Allergy Clin Immunol. 2000 Jun;105(6 Pt 1):1108-16.

PMID:
10856143
7.

Salmeterol improves quality of life in patients with asthma requiring inhaled corticosteroids. Salmeterol Quality of Life Study Group.

Kemp JP, Cook DA, Incaudo GA, Corren J, Kalberg C, Emmett A, Cox FM, Rickard K.

J Allergy Clin Immunol. 1998 Feb;101(2 Pt 1):188-95.

PMID:
9500751
8.

Ex vivo pharmacologic modulation of basophil histamine release in asthmatic patients.

Lebel B, Arnoux B, Chanez P, Bougeard YH, Daures JP, Bousquet J, Campbell AM.

Allergy. 1996 Jun;51(6):394-400.

PMID:
8837662
9.

Tiotropium in combination with placebo, salmeterol, or fluticasone-salmeterol for treatment of chronic obstructive pulmonary disease: a randomized trial.

Aaron SD, Vandemheen KL, Fergusson D, Maltais F, Bourbeau J, Goldstein R, Balter M, O'Donnell D, McIvor A, Sharma S, Bishop G, Anthony J, Cowie R, Field S, Hirsch A, Hernandez P, Rivington R, Road J, Hoffstein V, Hodder R, Marciniuk D, McCormack D, Fox G, Cox G, Prins HB, Ford G, Bleskie D, Doucette S, Mayers I, Chapman K, Zamel N, FitzGerald M; Canadian Thoracic Society/Canadian Respiratory Clinical Research Consortium.

Ann Intern Med. 2007 Apr 17;146(8):545-55. Epub 2007 Feb 19.

PMID:
17310045
10.

Long-acting beta 2-agonist salmeterol compared with albuterol in maintenance asthma therapy.

Pearlman DS.

Ann Allergy Asthma Immunol. 1995 Aug;75(2):180-4.

PMID:
7648385
11.

Improved refill persistence with fluticasone propionate and salmeterol in a single inhaler compared with other controller therapies.

Stoloff SW, Stempel DA, Meyer J, Stanford RH, Carranza Rosenzweig JR.

J Allergy Clin Immunol. 2004 Feb;113(2):245-51.

PMID:
14767437
13.

Effect of salmeterol on patients' adherence to their prescribed refills for inhaled corticosteroids.

Kelloway JS, Wyatt R, DeMarco J, Adlis S.

Ann Allergy Asthma Immunol. 2000 Mar;84(3):324-8.

PMID:
10752917
14.

Tiotropium bromide. A review of its use as maintenance therapy in patients with COPD.

Keam SJ, Keating GM.

Treat Respir Med. 2004;3(4):247-68. Review.

PMID:
15350163
15.
16.

Inhaled corticosteroids and asthma control in children: assessing impairment and risk.

Rachelefsky G.

Pediatrics. 2009 Jan;123(1):353-66. doi: 10.1542/peds.2007-3273. Review.

PMID:
19117903
17.

Adding salmeterol to an inhaled corticosteroid reduces allergen-induced serum IL-5 and peripheral blood eosinophils.

Koopmans JG, Lutter R, Jansen HM, van der Zee JS.

J Allergy Clin Immunol. 2005 Nov;116(5):1007-13. Epub 2005 Oct 3.

PMID:
16275368
18.

Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease.

Calverley PM, Anderson JA, Celli B, Ferguson GT, Jenkins C, Jones PW, Yates JC, Vestbo J; TORCH investigators.

N Engl J Med. 2007 Feb 22;356(8):775-89.

19.

Montelukast as add-on therapy to inhaled corticosteroids in the treatment of mild to moderate asthma: a systematic review.

Joos S, Miksch A, Szecsenyi J, Wieseler B, Grouven U, Kaiser T, Schneider A.

Thorax. 2008 May;63(5):453-62. doi: 10.1136/thx.2007.081596. Review.

PMID:
18443162
20.

A six-month, placebo-controlled comparison of the safety and efficacy of salmeterol or beclomethasone for persistent asthma.

Nathan RA, Pinnas JL, Schwartz HJ, Grossman J, Yancey SW, Emmett AH, Rickard KA.

Ann Allergy Asthma Immunol. 1999 Jun;82(6):521-9.

PMID:
10400478

Supplemental Content

Support Center